Insulin Nph Human Isophane
Brand name: Humulin N
Rank #271 of 500 drugs by total cost
$44.9M
Total Cost
172,714
Total Claims
$44.9M
Total Cost
6,717
Prescribers
$260
Cost per Claim
30,188
Beneficiaries
357,114
30-Day Fills
$6,687
Avg Cost/Provider
26
Avg Claims/Provider
About Insulin Nph Human Isophane
Insulin Nph Human Isophane (sold as Humulin N) was prescribed 172,714 times by 6,717 Medicare Part D providers in 2023, costing the program $44.9M. At $260 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
| 270 | Amantadine Hcl (Amantadine) | $45.2M | 173,840 |
| 271 | Insulin Nph Human Isophane (Humulin N) | $44.9M | 172,714 |
| 272 | Bosutinib (Bosulif) | $44.9M | 2,962 |
| 273 | Tramadol Hcl (Tramadol Hcl) | $44.9M | 5,226,406 |
| 274 | Finasteride (Finasteride) | $44.6M | 2,766,115 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology